• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB 3.85% 37.5¢

DIMERIX LIMITED

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB 14/11/24 27 9.0K
14/11/24 Last post  JTrain3000 Comments Created with Sketch.  27  Views Created with Sketch.  9.0K 
DXB
DXB Chart
26 27 28
14/11/24 1.6K 661K
14/11/24 Last post  investor901 Comments Created with Sketch.  1.6K  Views Created with Sketch.  661K 
DXB
DXB - Research & Valuation
2 3 4
13/11/24 234 116K
Metals & Mining SECTOR NEWS

Red Mountain Mining (ASX:RMX) announces high-grade nickel discovery at Kiabye project

RMX
14 Nov 2024
RED MOUNTAIN MINING LIMITED
13/11/24 Last post  manishv Comments Created with Sketch.  234  Views Created with Sketch.  116K 
DXB 08/11/24 0 403
08/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  403 
DXB
Dimerix (ASX: DXB) Discussion Thread
10 11 12
08/11/24 685 248K
08/11/24 Last post  Mani86 Comments Created with Sketch.  685  Views Created with Sketch.  248K 
DXB 07/11/24 0 369
07/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  369 
DXB
DXB Media thread.
3 4 5
05/11/24 287 159K
05/11/24 Last post  ma420 Comments Created with Sketch.  287  Views Created with Sketch.  159K 
DXB 01/11/24 14 6.5K
01/11/24 Last post  unitfree2 Comments Created with Sketch.  14  Views Created with Sketch.  6.5K 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - DXB
08 Nov 14:11
 
Application for quotation of securities - DXB
07 Nov 12:32
 
Dimerix to Host Technical Webinar on PARASOL FSGS Insights
06 Nov 08:29
 
NEPTUNE Study Network to Enhance Phase 3 Recruitment in US
01 Nov 08:27
 
Quarterly Appendix 4C and Activities Report
31 Oct 08:24
 
Project PARASOL Update & Medical Advisory Board Appointment
28 Oct 09:10
 
View More arrow Created with Sketch.
(20min delay)
Last
37.5¢
Change
-0.015(3.85%)
Mkt cap ! $209.1M
Open High Low Value Volume
39.0¢ 39.0¢ 36.8¢ $774.4K 2.057M

Buyers (Bids)

No. Vol. Price($)
3 134968 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 31000 2
View Market Depth
Last trade - 16.10pm 14/11/2024 (20 minute delay) ?
Last
37.5¢
  Change
-0.015 ( 2.60 %)
Open High Low Volume
38.0¢ 38.5¢ 36.5¢ 1258620
Last updated 15.44pm 14/11/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.